Hanson James S.
Former Officer at FTRE; General Counsel at G1 Therapeutics, Inc.
- Sold, on record
- $64k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Sep 9, 2025
- Form 144 notices
- 4
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- FTREFortrea Holdings Inc.Former Officer
- G1 Therapeutics, Inc.General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- FTRE4,875 shares
- G1 Therapeutics, Inc.3,813 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale G1 Therapeutics, Inc.Plan not statedJan 5, 2023 2023
Sold 2,368 shares at $5.53 ($13k)
Hanson James S., General Counsel
Sold 5.4% of holdings ($240k position)41,087 shares leftFiling
- 2 Form 144 notice FTRENoticeMar 14, 2025 +799 days
Filed to sell 1,007 shares ($10k)
Hanson James S., Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale FTRENo planMar 14, 2025 same day
Sold 1,007 shares at $9.70 ($10k)
Hanson James S., General Counsel
No 10b5-1 planSold 9.6% of holdings ($102k position)9,466 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice FTRENoticeJun 3, 2025 +81 days
Filed to sell 2,191 shares ($9k)
Hanson James S., Officer
No 10b5-1 planFiling
- 5 Form 4 sale FTRENo planJun 3, 2025 same day
Sold 2,191 shares at $4.17 ($9k)
Hanson James S., General Counsel
No 10b5-1 planSold 12.8% of holdings ($72k position)14,981 shares leftFollows a Form 144Filing
- 6 Form 144 notice FTRENoticeSep 9, 2025 +98 days
Filed to sell 1,677 shares ($17k)
Hanson James S., Officer
No 10b5-1 planFiling
- 7 Form 4 sale FTRENo planSep 9, 2025 same day
Sold 1,677 shares at $10.23 ($17k)
Hanson James S., General Counsel
No 10b5-1 planSold 8.1% of holdings ($212k position)19,092 shares leftFollows a Form 144Filing
- 8 Form 144 notice FTRENoticeJan 20, 2026 +133 days
Filed to sell 27,736 shares ($432k)
Hanson James S., Former Officer
No 10b5-1 plan16.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (9)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 | Jan 20, 2026 | FTRE | Former Officer | Form 144 notice | 27,736 | $432k | Notice | SEC | |
| Sep 9, 2025 | Sep 10, 2025 | FTRE | General Counsel | Form 4 sale | 1,677 | $17k | 8.1% | No plan | SEC |
| Sep 9, 2025 | Sep 9, 2025 | FTRE | Officer | Form 144 notice | 1,677 | $17k | Notice | SEC | |
| Jun 3, 2025 | Jun 4, 2025 | FTRE | General Counsel | Form 4 sale | 2,191 | $9k | 12.8% | No plan | SEC |
| Jun 3, 2025 | Jun 3, 2025 | FTRE | Officer | Form 144 notice | 2,191 | $9k | Notice | SEC | |
| Mar 14, 2025 | Mar 17, 2025 | FTRE | General Counsel | Form 4 sale | 1,007 | $10k | 9.6% | No plan | SEC |
| Mar 14, 2025 | Mar 14, 2025 | FTRE | Officer | Form 144 notice | 1,007 | $10k | Notice | SEC | |
| Jan 5, 2023 | Jan 5, 2023 | G1 Therapeutics, Inc. | General Counsel | Form 4 sale | 2,368 | $13k | 5.4% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 5, 2022 | G1 Therapeutics, Inc. | General Counsel | Form 4 sale | 1,445 | $15k | 5.4% | Plan not stated | SEC |